Carnegie Mellon University

Abbott Lab

Departments of Biomedical Engineering and Materials Science and Engineering

The Abbott lab at Carnegie Mellon University works at the interface of materials science and regenerative medicine. We investigate how the 3D microenvironment affects tissue development and disease. Our current research focuses on adipose tissue engineering strategies, silk biomaterials and non-invasive tissue assessments to study obesity and it's link to type II diabetes. For more information about what we do, check out our current research projects, publications, and outreach events. To join our team please contact us!

 


Professor Abbott is featured on "My Future Tech Podcast!" 

Recent updates

2/2024 Liz gives a seminar at the PGH Assembloid meeting titled "Developing a novel defatting cocktail for steatotic livers."

2/2024 Prof. Abbott is quoted in the Tech Times article: “A 3D Printer Can Now Design Custom Chocolates.”

2/2024 Prof. Abbott is notified she will be promoted to Associate Professor!

1/2024 Prof. Abbott attends the Tufts Cellular Agriculture Innovation Day and takes part in the “Cultured Meat Safety Initiative” with New Harvest and Vireo Advisors.

1/2024 Prof. Abbott is awarded the BMES Cellular and Molecular Bioengineering Rising Star Award and gives a talk at the annual conference.

Check out more recent events in the group…

Recent Publications

Huff LK, Ling Z, DeBari MK, Ren X, Abbott RD. “Repurposing Decellularized Lungs to Generate Vascularized Fat.” Adipose-Derived Stem Cells Methods and Protocols. 3rd edition. Edited by Jeffrey Gimble, Bruce Bunnell, Cecilia Sanchez, and Trivia Frazier. Lab protocol Series - Methods in Molecular Biology, published by Springer Nature 2024.

Dewal RS, Yang FT, Baer LA, Vidal P, Hernandez-Saavedra D, Seculov NP, Ghosh A, Noé F, Togliatti O, Hughes L, DeBari MK, West MD, Soroko R, Sternberg H, Malik NN, Puchulu-Campanella E, Wang H, Yan P, Wolfrum C, Abbott RD, Stanford KI. Transplantation of Committed Pre-adipocytes from Brown Adipose Tissue improves Whole-body Glucose Homeostasis. iScience. 2024 Jan 17.

Pre-print: DeBari MK, Johnston EK, Griffin MD, Scott JV, Ilzuka E, Sun W, Webster-Wood VA, Abbott RD. Human subcutaneous adipose tissue variability is driven by TGIF1, ACTA2, adipocyte density, and ancestral history of the patient. Submitted May 31, 2023 to eLife with a preprint available at biorxiv.org.

Check out more publications from the group...